MicroRNA‑329‑3p alleviates high glucose‑induced endothelial cell injury via inhibition of the TLR4/TRAF6/NF‑&kappa;B signaling pathway

Song,Guangzhao; Li,Liyan; Yang,Ying

doi:10.3892/etm.2020.9461

MicroRNA‑329‑3p alleviates high glucose‑induced endothelial cell injury via inhibition of the TLR4/TRAF6/NF‑κB signaling pathway

Authors:
- Guangzhao Song
- Liyan Li
- Ying Yang
View Affiliations

Affiliations: Department of Endocrinology, The First People's Hospital of Jinan, Jinan, Shandong 250011, P.R. China, Department of Medicine, Licheng District Maternal and Child Healthcare and Family Planning Service Center, Jinan, Shandong 250100, P.R. China
Published online on: November 10, 2020 https://doi.org/10.3892/etm.2020.9461
Article Number: 29
Copyright: © Song et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the current study was to determine the expression of microRNA (miRNA/miR)‑329‑3p in patients with type 2 diabetes mellitus (T2DM) and to investigate the effect of miR‑329‑3p on vascular endothelial cell function under high‑glucose conditions. A total of 33 healthy individuals and 31 patients with T2DM were enrolled in the present study. Peripheral blood was collected from all participants. Human umbilical vein endothelial cells (HUVECs) were transfected with a miR‑329‑3p mimic or miR‑329‑3p inhibitor. Following treatment with 25 mmol/l glucose, a Cell Counting Kit‑8 assay and flow cytometry analysis were used to assess cell viability and apoptosis levels, respectively. A dual luciferase reporter assay, western blot analysis and reverse transcription‑quantitative PCR were used to assess molecular mechanism of miR‑329‑3p in HUVECs. The results revealed that plasma miR‑329‑3p expression was decreased patients with T2DM compared with healthy controls, and in HUVECs treated with high glucose concentrations. In addition, miR‑329‑3p reduced high glucose‑induced damage to HUVEC cells. miR‑329‑3p directly bound to toll like receptor (TLR)‑4 and regulated its expression at the transcriptional and post‑transcriptional levels. miR‑329‑3p was also demonstrated to be involved in the regulation of the TLR4/tumor necrosis factor receptor associated factor 6 (TRAF6)/nuclear factor (NF)‑κB signaling pathway and the nuclear translocation of NF‑κB under a high glucose environment. In conclusion, the results indicated that miR‑329‑3p may protect endothelial cells from high glucose‑induced apoptosis via inhibition of the TLR4/TRAF6/NF‑κB signaling pathway. The present study also demonstrated that miR‑329‑3p expression in the plasma of patients with T2DM was reduced, suggesting that upregulation of miR‑329‑3p may alleviate high glucose‑induced endothelial cell injury via inhibition of the TLR4/TRAF6/NF‑κB signaling pathway.

View Figures

View References

1	Hurlow JJ, Humphreys GJ, Bowling FL and McBain AJ: Diabetic foot infection: A critical complication. Int Wound J. 15:814–821. 2018.PubMed/NCBI View Article : Google Scholar
2	Knapp M, Tu X and Wu R: Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol Sin. 40:1–8. 2019.PubMed/NCBI View Article : Google Scholar
3	Eelen G, de Zeeuw P, Simons M and Carmeliet P: Endothelial cell metabolism in normal and diseased vasculature. Circ Res. 116:1231–1244. 2015.PubMed/NCBI View Article : Google Scholar
4	Nakagami H, Kaneda Y, Ogihara T and Morishita R: Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis. Curr Diabet Rev. 1:59–63. 2005.PubMed/NCBI View Article : Google Scholar
5	Mirra P, Raciti GA, Nigro C, Fiory F, D'Esposito V, Formisano P, Beguinot F and Miele C: Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes. Epigenomics. 7:653–667. 2015.PubMed/NCBI View Article : Google Scholar
6	Hou LJ, Han JJ and Liu Y: Up-regulation of microRNA-503 by high glucose reduces the migration and proliferation but promotes the apoptosis of human umbilical vein endothelial cells by inhibiting the expression of insulin-like growth factor-1 receptor. Eur Rev Med Pharmacol Sci. 22:3515–3523. 2018.PubMed/NCBI View Article : Google Scholar
7	Hui Y and Yin Y: MicroRNA-145 attenuates high glucose-induced oxidative stress and inflammation in retinal endothelial cells through regulating TLR4/NF-kappaB signaling. Life Sci. 207:212–218. 2018.PubMed/NCBI View Article : Google Scholar
8	Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC and Cavaille J: A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res. 14:1741–1748. 2004.PubMed/NCBI View Article : Google Scholar
9	Benetatos L, Hatzimichael E, Londin E, Vartholomatos G, Loher P, Rigoutsos I and Briasoulis E: The microRNAs within the DLK1-DIO3 genomic region: Involvement in disease pathogenesis. Cell Mol Life Sci. 70:795–814. 2013.PubMed/NCBI View Article : Google Scholar
10	Welten SM, Bastiaansen AJ, de Jong RC, de Vries MR, Peters EA, Boonstra MC, Sheikh SP, La Monica N, Kandimalla ER, Quax PH and Nossent AY: Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 increases neovascularization and blood flow recovery after ischemia. Circ Res. 115:696–708. 2014.PubMed/NCBI View Article : Google Scholar
11	Wang P, Luo Y, Duan H, Xing S, Zhang J, Lu D, Feng J, Yang D, Song L and Yan X: MicroRNA 329 suppresses angiogenesis by targeting CD146. Mol Cell Biol. 33:3689–3699. 2013.PubMed/NCBI View Article : Google Scholar
12	Vaure C and Liu YL: ‘A comparative review of toll-like receptor 4 expression and functionality in different animal species’. Front Immunol. 5(316)2014.PubMed/NCBI View Article : Google Scholar
13	Hu L, Yang H, Ai M and Jiang S: Inhibition of TLR4 alleviates the inflammation and apoptosis of retinal ganglion cells in high glucose. Graefes Arch Clin Exp Ophthalmol. 255:2199–2210. 2017.PubMed/NCBI View Article : Google Scholar
14	Ye EA and Steinle JJ: miR-146a attenuates inflammatory pathways mediated by TLR4/NF-κB and TNFα to protect primary human retinal Microvascular endothelial cells grown in high glucose. Mediators Inflamm. 2016(3958453)2016.PubMed/NCBI View Article : Google Scholar
15	Zhang TH, Huang CM, Gao X, Wang JW, Hao LL and Ji Q: Gastrodin inhibits high glucose-induced human retinal endothelial cell apoptosis by regulating the SIRT1/TLR4/NF-κBp65 signaling pathway. Mol Med Rep. 17:7774–7780. 2018.PubMed/NCBI View Article : Google Scholar
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta c(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
17	Wang X, Lu X, Zhang T, Wen C, Shi M, Tang X, Chen H, Peng C, Li H, Fang Y, et al: mir-329 restricts tumor growth by targeting grb2 in pancreatic cancer. Oncotarget. 7:21441–21453. 2016.PubMed/NCBI View Article : Google Scholar
18	Jiang W, Liu J, Xu T and Yu X: MiR-329 suppresses osteosarcoma development by downregulating Rab10. FEBS Lett. 590:2973–2981. 2016.PubMed/NCBI View Article : Google Scholar
19	Li Z, Yu X, Wang Y, Shen J, Wu WK, Liang J and Feng F: By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth. Oncotarget. 6:17559–17569. 2015.PubMed/NCBI View Article : Google Scholar
20	Xiao B, Tan L, He B, Liu Z and Xu R: MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells. J Transl Med. 11(172)2013.PubMed/NCBI View Article : Google Scholar
21	Gordon S: Pattern recognition receptors: Doubling up for the innate immune response. Cell. 111:927–930. 2002.PubMed/NCBI View Article : Google Scholar
22	Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC and Jialal I: Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: Further evidence of a proinflammatory state. J Clin Endocrinol Metab. 93:578–583. 2008.PubMed/NCBI View Article : Google Scholar
23	Dasu MR, Devaraj S, Park S and Jialal I: Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care. 33:861–868. 2010.PubMed/NCBI View Article : Google Scholar
24	Garibotto G, Carta A, Picciotto D, Viazzi F and Verzola D: Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy. J Nephrol. 30:719–727. 2017.PubMed/NCBI View Article : Google Scholar